Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease
Abstract The erythropoietin receptor (EpoR) was discovered and described in red blood cells (RBCs), stimulating its proliferation and survival. The target in humans for EpoR agonists drugs appears clear—to treat anemia. However, there is evidence of the pleitropic actions of erythropoietin (Epo). Fo...
-д хадгалсан:
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2013-04-01
|
| Цуврал: | Molecular Medicine |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.2119/molmed.2013.00025 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|